News

Market Update: U.S. Stocks Rise

1 Mins read

U.S. stocks ended higher on Wednesday as yields on long government bonds eased, resulting in the best day for the S&P 500 in three weeks. The Dow Jones Industrial Index gained about 125 points, or 0.4%, finishing near 33,128. Although this boost failed to bring the blue-chip index into positive territory for the year, it came a day after its gains for 2023 were wiped out.

The S&P 500 index rose 0.8%, marking its largest daily climb since September 14. Meanwhile, the Nasdaq Composite Index shot up 1.4%. The surge in U.S. bond yields since late September has led to buyer reluctance and created market ripples. The Federal Reserve’s indication of higher rates for a longer duration to combat inflation initiated this sharp bond-market repricing.

On Wednesday, the 10-year Treasury yield fell 6.6 basis points to 4.735%, while the 30-year Treasury yield shed 6 basis points to 4.876%, after briefly surpassing 5% on Tuesday. Investors are closely monitoring political upheaval in Washington and the possibility of a November government shutdown. Additionally, the monthly jobs report for September, scheduled for release on Friday, is expected to show a cooling labor market with a steady 3.7% unemployment rate.

Stay informed with the latest market updates!

Related posts
News

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…
News

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…
News

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

58 − = 52